| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |